Status:
UNKNOWN
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
Lead Sponsor:
Shanghai 6th People's Hospital
Conditions:
Bone Marrow Metastases
Magnetic Resonance Imaging
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to study the value and feasibility of magnetic resonance imaging in detection of bone marrow metastases
Detailed Description
The patient was diagnosed as bone metastasis by pathology. CT showed no bone marrow biopsy site metastasis (anterior iliac spine or posterior iliac spine). After functional magnetic resonance examinat...
Eligibility Criteria
Inclusion
- Patients with malignant tumors (solid tumors or hematological malignancies) were definitely diagnosed by pathology or cytology.
- patients with bone metastases confirmed by more than two imaging examinations.
- Age 18-75.
- ECOG score: 0-2.
- The expected survival time is more than 3 months.
- Sign the informed consent.
Exclusion
- Imaging findings suggest that bone metastases are present at the bone marrow puncture site.
- The patient refused bone marrow puncture.
- Puncture site with infection.
- Severe coagulation dysfunction.
- There are implanted instruments in the body, so magnetic resonance imaging can not be performed.
Key Trial Info
Start Date :
May 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03876392
Start Date
May 10 2019
End Date
December 31 2022
Last Update
August 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Sixth People'S Hospital
Shanghai, Other (Non U.s.), China, 200233